(Q39925879)

15 September 2017

title

The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells (English)

1 reference

oral squamous cell carcinoma

15 September 2017

1 reference

1 reference

T Katsura

1

1 reference

15 September 2017

S Iwai

2

1 reference

15 September 2017

Y Ota

3

1 reference

15 September 2017

H Shimizu

4

1 reference

15 September 2017

K Ikuta

5

1 reference

15 September 2017

Y Yura

6

1 reference

15 September 2017

publication date

24 October 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

16

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

237-245

1 reference

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Enhancement of antitumor activity of herpes simplex virus gamma(1)34.5-deficient mutant for oral squamous cell carcinoma cells by hexamethylene bisacetamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

The IKK complex: an integrator of all signals that activate NF-kappaB?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Inhibitors of histone deacetylase as new anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Histone deacetylases and cancer: causes and therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Anticancer activities of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Anti-tumor activity of N-hydroxy-7-(2-naphthylthio) heptanomide, a novel histone deacetylase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Duration of nuclear NF-kappaB action regulated by reversible acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Herpes simplex type 1 induction of persistent NF-kappa B nuclear translocation increases the efficiency of virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Herpes simplex virus disrupts NF-kappaB regulation by blocking its recruitment on the IkappaBalpha promoter and directing the factor on viral genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Activation of NF-kappaB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Inhibition of nuclear factor-kappaB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of her

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Potential for efficacy of the oncolytic Herpes simplex virus 1716 in patients with oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Trichostatin A and oncolytic HSV combination therapy shows enhanced antitumoral and antiangiogenic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.81

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2008.81

1 reference

15 September 2017

1 reference